Rising penetration of trade generic medicines is eating into the value growth of the domestic pharmaceutical market, showed a recent analysis.
According to a Kotak Institutional Equities analysis, 70-111 basis points (bps) annual dent is expected from trade generics and Jan Aushadhi on Indian Pharma Market (IPM) growth at least until FY27-28 (see chart).
Trade generic medicines are those that are not pushed into the market through doctor promotions.
Rather, pharma companies supply these medicines directly to the distributors.
Typically, trade generic medicines are available at a 50-60 per cent discount to branded generic medicines as there is no marketing expense incurred.
The Centre is targeting to increase the Jan Aushadhi store count by 2.5 times to 25,000 in less than two and half years (end of FY26). As of November 2023, there are 10,006 Jan Aushadhi stores opened across 753 districts in the country. Around 33 per cent of the stores are now in South India, with a high skew towards Karnataka and Kerala. As such, UP has the highest number of Jan Aushadhi stores (1,481).
Bu hikaye Business Standard dergisinin December 26, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Giriş Yap
Bu hikaye Business Standard dergisinin December 26, 2023 sayısından alınmıştır.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Giriş Yap
Supreme Industries stock slips on weak Q2 showing
Brokerages cut earnings estimates after firm disappointed the Street
Dabur stock fall may provide entry to long-term investors
Dabur's performance in the July-September quarter of the current financial year (Q2FY25) was weak but in line with consensus. Consolidated revenue declined 5 per cent year-on-year (Y-o-Y) due to a temporary adjustment in General Trade (GT) inventory.
Capital markets' boom drives NSE Q2 PAT up 57% at ₹3.14K crore
The National Stock Exchange (NSE) reported a 57 per cent year-on-year (Y-o-Y) jump in consolidated net profit to ₹3,137 crore during the quarter ended September 2024 (Q2 FY25) amid a boom in the capital markets.
Sebi directs Embassy Reit to suspend CEO Aravind Maiya
The Securities and Exchange Board of India (Sebi) on Monday directed Embassy Office Parks Management Services, manager to the Embassy Real Estate Investment Trust (Reit), to suspend its chief executive officer Aravind Maiya for lapses in the \"fit and proper\" criteria.
Quant MF expects market correction to pave the way for risk-on phase
The recent downturn in the equity market may see a reversal once the US elections are over, according to Quant Mutual Fund, which emphasizes that the last month's correction should be seen as an opportunity to build more resilient and rewarding portfolios.
Mid, smallcap bounceback may be a distant dream
Analysts believe markets lack positive triggers for an immediate turnaround amid looming US polls
Sebi allows MFs to invest in overseas schemes with India exposure
The Securities and Exchange Board of India (Sebi) has allowed mutual funds (MFs) to invest in overseas funds and unit trusts (UTs) that have up to 25 per cent exposure to Indian equities.
Worst not over yet? Mkt selloff may continue amid headwinds
Technical charts suggest Sensex can slide to 72,000 levels in the worst-case scenario
New York Times beats estimates as digital subscriber count grows
New York Times Co reported third-quarter earnings that beat analysts' expectations, as the company saw an increase in its subscriber count in the months leading up to the 2024 Presidential Election.
Pak blames 'winds from India' as Lahore AQI hits record high
Ministers in Pakistan's Punjab province on Monday blamed winds from India for worsening the smog, urging the Indian authorities to take the matter seriously, after the air quality index (AQI) in Lahore hit a record high over the weekend.
